Growth Metrics

Bioregenx (BRGX) Change in Account Payables (2022 - 2025)

Bioregenx has reported Change in Account Payables over the past 4 years, most recently at $156339.0 for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 262.39% year-over-year to $156339.0; the TTM value through Dec 2025 reached $188512.0, up 2178.92%, while the annual FY2025 figure was $188512.0, 2178.92% up from the prior year.
  • Change in Account Payables for Q4 2025 was $156339.0 at Bioregenx, up from -$109148.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $156339.0 in Q4 2025 and troughed at -$295866.0 in Q3 2023.
  • A 4-year average of -$4323.3 and a median of $4635.5 in 2022 define the central range for Change in Account Payables.
  • On a YoY basis, Change in Account Payables climbed as much as 3914.29% in 2023 and fell as far as 10158.88% in 2023.
  • Year by year, Change in Account Payables stood at $2355.0 in 2022, then surged by 3515.03% to $85134.0 in 2023, then crashed by 49.33% to $43141.0 in 2024, then skyrocketed by 262.39% to $156339.0 in 2025.
  • Business Quant data shows Change in Account Payables for BRGX at $156339.0 in Q4 2025, -$109148.0 in Q3 2025, and $141056.0 in Q2 2025.